Back

Cost-effectiveness of atrial fibrillation detection with insertable cardiac monitors in large-artery or small-vessel disease stroke in the United Kingdom

7 April 2024 (08:30 - 15:00)
Organised by: Logo
Congress Presentation Part of: Miscellaneous 2 Telehealth EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Klaus Witte

Leeds Institute of Cardiovascular and Metabolic Medicine, Leeds (United Kingdom of Great Britain & Northern Ireland)

8 More presentations in this session

Presentation thumbnail
Recording of chest leads via mobile ECG and quantitative correlation with Wilson leads in a patient with monomorphic PVCs
Doctor J. Mueller-Leisse (Hannover, DE)
Abstract Slides Video
Presentation thumbnail
In vivo KCNQ1-suppression-replacement gene therapy in transgenic LQT1 rabbits restores a physiological QT interval at baseline and under catecholamine infusion
Ms L. Giammarino (Rochester, US)
Abstract Slides Video
Presentation thumbnail
From ECG to broadband ECG, focused on the ventricular activation
Doctor P. Jurak (Brno, CZ)
Abstract Slides Video
Presentation thumbnail
Machine learning approach for prediction of outcomes in anticoagulated patients with atrial fibrillation
Doctor A. Bernardini (Florence, IT)
Abstract Slides Video
Presentation thumbnail
Influence of tissue-electrode distance on unipolar and bipolar voltage for large-tip, ring-, and mini-electrodes
Doctor S. Knecht (Basel, CH)
Abstract Slides Video

Access the full session

Session thumbnail
Miscellaneous 2

The Event

Event poster

EHRA 2024

7 April - 9 April 2024
You may be interested in
thumbnail
Congress Presentation
Economic and clinical impact of diagnostic sensitivity for insertable cardiac monitors in the United Kingdom
thumbnail
Congress Presentation
Cost-effectiveness of AF ablation versus medical therapy for the treatment of atrial fibrillation and heart failure.
thumbnail
Congress Presentation
Quality of life after screening for atrial fibrillation: a substudy from a randomised screening trial

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources